Dimethylformamide → HCID 86609333, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([N:21]2[CH2:25][C@H:24]([CH2:26][N:27]3[CH:31]=[CH:30][N:29]=[N:28]3)[O:23][C:22]2=[O:32])[CH:5]=[CH:6][C:7]=1[C:8]1[CH:9]=[N:10][C:11]([C:14]2[CH2:18][C@@H:17]([CH2:19][OH:20])[O:16][N:15]=2)=[CH:12][CH:13]=1.[CH3:33][N:34]([CH3:42])[CH:35]([CH3:41])[CH2:36][CH2:37][C:38](O)=[O:39].Cl.C(N=C=NCCCN(C)C)C.CN(C=O)C>CN(C)C1C=CN=CC=1.CCOC(C)=O>[CH3:33][N:34]([CH3:42])[CH:35]([CH3:41])[CH2:36][CH2:37][C:38]([O:20][CH2:19][C@H:17]1[O:16][N:15]=[C:14]([C:11]2[CH:12]=[CH:13][C:8]([C:7]3[CH:6]=[CH:5][C:4]([N:21]4[CH2:25][C@H:24]([CH2:26][N:27]5[CH:31]=[CH:30][N:29]=[N:28]5)[O:23][C:22]4=[O:32])=[CH:3][C:2]=3[F:1])=[CH:9][N:10]=2)[CH2:18]1)=[O:39]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
(5R)-3-(3-Fluoro-4-{6-[(5S)-5-(hydroxymethyl)-4,5-dihydroisoxazol-3-yl]pyridin-3-yl}phenyl)-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one (Example 1,150 mg, 0.342 mmol), 4-(dimethylamino)pentanoic acid (63.6 mg, 0.514 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (131.5 mg, 0.69 mmol), and 4-dimethylaminopyridine (10.5 mg, 0.09 mmol) were added to DMF (3 ml). The reaction was allowed to stir overnight at room temperature followed by addition to EtOAc (40 ml). The precipitate was collected by filtration and then purified by column chromatography 0–5% MeOH/CH2Cl2 to yield a white powder (100 mg).
Workup
- filtrationThe precipitate was collected by filtration
- custompurified by column chromatography 0–5% MeOH/CH2Cl2
Sources & evidence
- ORD record
- ord-6235b2e32e484934acb1eb3fcf835fa7
- Source dataset
- uspto-grants-2007_03
- Patent number
- US07192974B2
Reaction notes
Loading…